{"url":"https://newsforagent.com/news/2026-10-28/medidata-idc-marketscape-leader-rwd-rwe","markdown_url":"https://newsforagent.com/news/2026-10-28/medidata-idc-marketscape-leader-rwd-rwe.md","title":"Medidata Named IDC MarketScape Leader for RWD/RWE","headline":"Medidata Named a Leader in IDC MarketScape for Real-World Data and Evidence Services","description":"Medidata was named a Leader in IDC MarketScape's assessment of life sciences RWD/RWE platforms, technology and consulting.","section":"Business","published_at":"2026-10-28T06:18:17+00:00","modified_at":"2026-10-28T06:18:17+00:00","author":"News Desk","key_takeaways":["Medidata was named a Leader in the IDC MarketScape for worldwide life sciences R&D RWD/RWE data platforms, technology solutions and consulting services.","Medidata's clinical dataset covers more than 42,000 trials and 13 million patients, with over 1 million registered users across approximately 2,300 customers.","Medidata launched Medidata Plus, an AI-native platform layer, in July 2026 and expanded its executive leadership team in August 2026."],"companies":[{"name":"Medidata","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0004o5j/medidata","website":"https://www.medidata.com"},{"name":"IDC","is_primary":false,"profile_url":"https://akta.pro/company-profiles/0000bce/idc","website":"http://www.idc.com"}],"source":{"publisher":"Financial Post","title":"Medidata Named by IDC MarketScape™ as a Leader in Worldwide Life Sciences R&D RWD/RWE Data Platforms, Technology Solutions, and Consulting Services","url":"https://financialpost.com/globe-newswire/medidata-named-by-idc-marketscape-as-a-leader-in-worldwide-life-sciences-rd-rwd-rwe-data-platforms-technology-solutions-and-consulting-services"},"other_sources":[],"tags":["Business","Medidata","IDC"],"body_markdown":"[Medidata](https://akta.pro/company-profiles/0004o5j/medidata) was named a Leader in the [IDC](https://akta.pro/company-profiles/0000bce/idc) MarketScape for worldwide life sciences R&D real-world data and real-world evidence data platforms, technology solutions and consulting services, the [Financial Post](https://financialpost.com/globe-newswire/medidata-named-by-idc-marketscape-as-a-leader-in-worldwide-life-sciences-rd-rwd-rwe-data-platforms-technology-solutions-and-consulting-services) reported on October 28, 2026. Medidata is a Dassault Systèmes brand that provides AI-powered clinical trial software for study, patient and data workflows.\n\n## How IDC MarketScape Scores Vendors\n\nThe IDC MarketScape model scores technology and service suppliers on qualitative and quantitative criteria and plots each vendor's position in a single graphical illustration for a given market. IDC says the framework lets buyers compare product and service offerings, capabilities and strategies, and current and future market success factors, and gives them a 360-degree assessment of vendors' strengths and weaknesses.\n\nMedidata said it has supported clinical trials for more than 25 years and describes its portfolio as AI-powered solutions spanning the trial lifecycle, aimed at accelerating clinical breakthroughs, reducing patient and site burden and bringing therapies to market faster. The company said its Study, Patient and Data Experiences are trusted by more than 1 million registered users across approximately 2,300 customers, supported by a clinical dataset of more than 42,000 trials and 13 million patients. Medidata said it is also recognized as a leader by Everest Group and IDC.\n\n## Medidata's Scale in Company Records\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Medidata's platform supports 38,000+ trials and 12M+ patients and serves roughly 2,300 biopharma, biotech, MedTech, CRO and academic medical center customers. The same records show 80% of all FDA novel drug approvals in 2025 were supported by Medidata's platform, the company advances 70% of new molecular entities and it designs over 50% of all medical devices. Medidata was founded in 2000, is headquartered in New York and operates as a wholly-owned brand of Dassault Systèmes, with a revenue estimate of $500 million-$1 billion.\n\n## Medidata Plus and Leadership Changes\n\nMedidata launched Medidata Plus, an AI-native platform layer that unifies AI capabilities across the clinical trial lifecycle from study build to data management and risk monitoring, PR Newswire APAC reported on July 30, 2026. On August 10, 2026, FinancialContent Business Page reported that Medidata appointed Lisa Moneymaker as chief operating officer alongside her chief strategy officer role, Ian Marks as chief commercial officer, Jeff Ventimiglia as senior vice president of operations and transformation and Linda Magrath as senior vice president of customer success. In June 2026, Clinical Trials Arena reported that Medidata established an Academic Site Advisory Board at a Chicago meeting to address operational hurdles at academic medical centers.\n\n## What the IDC Report Covers\n\nThe IDC MarketScape report assessed vendors in worldwide life sciences R&D RWD/RWE data platforms, technology solutions and consulting services, and Medidata linked to the full report in its announcement.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}